Vimarsana
Biggest News Aggregation in the World

Page 12 - Equities Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Equities Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Equities Corp Today - Breaking & Trending Today

TrustBIX Inc. Announces Letter of Intent, Private Placement, Investor Relations Services, and Stock Option Grants - Vimarsana News

TrustBIX Inc. Announces Letter of Intent, Private Placement, Investor Relations Services, and Stock Option Grants

Acquisition letter of intent Edmonton, Alberta--(Newsfile Corp. - February 2, 2022) - TrustBIX Inc. (TSXV: TBIX) (OTCQB: TBIXF) ("TrustBIX" or the "Company") is pleased to announce the signing of a non-binding

Liquid Media retains marketing firm North Equities - Vimarsana News

Liquid Media retains marketing firm North Equities

LOS ANGELES, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Liquid Media Group Ltd. (“the Company,” “Liquid Media” or “Liquid”) (Nasdaq: YVR) is pleased to announce...

Liquid Media retains marketing firm North Equities - Press Release - Vimarsana News

Liquid Media retains marketing firm North Equities - Press Release

LOS ANGELES, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Liquid Media Group Ltd. ("the Company," "Liquid Media" or "Liquid") (NASDAQ:YVR) is pleased to announce

Ventura County Multifamily Sells for Nearly $40 Million | San Fernando Valley Business Journal - Vimarsana News

Ventura County Multifamily Sells for Nearly $40 Million | San Fernando Valley Business Journal

Calabasas-based Marcus & Millichap Inc. has brokered the sale of Ocean Villas, a 119-unit residential complex in Oxnard for $39.8 million.

Source: sfvbj.com
BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors - Vimarsana News

BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors

BriaCell Therapeutics Corp. a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, is pleased to welcome the appointment of Jane Gross, Ph.D. to its Board of Directors. Dr. Jane Gross is a highly experienced biotech executive with over 30 years in leading research and development teams from discovery through preclinical evaluation and clinical ...